IRDye800CW-exendin-4

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIRDye800CW-exendin-4
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesRadboud University Nijmegen
China Registration ClassN/A

Develop Information

Active CompaniesRadboud University Nijmegen
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A